Análisis de la satisfacción de los participantes en el Programa de detección precoz de cáncer colorrectal de Barcelona: valoración positiva de la farmacia comunitaria

Burón, Andrea; Posso, Margarita; Sivilla, Judit; Grau, Jaume; Guayta, Rafael; Castells, Xavier; Castells, Antoni; Macià, Francesc

doi:10.1016/j.gastrohep.2016.04.015

Cited by 9 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This emphasizes the willingness and motivation of CPs regarding pharmacist expanded role in skin healthcare. Presumably, an incentive to increase participation among pharmacists would be to establish a fee for the screening program, similarly to other screenings found in our NHS service portfolio 29,52. Secondly, we managed to reach 1% of our target population, a relatively small proportion, but an interesting milestone, since it is the first skin cancer screening strategy developed in our context.…”

Section: Discussionmentioning

confidence: 98%

Role of community pharmacists in skin cancer screening: A descriptive study of skin cancer risk factors prevalence and photoprotection habits in Barcelona, Catalonia, Spain

Mir¹,

Estrada-Campmany²,

Heredia³

et al. 2019

Pharm Pract (Granada)

View full text Add to dashboard Cite

Background:Skin cancer incidence is increasing alarmingly, despite current efforts trying to improve its early detection. Community pharmacists have proven success in implementing screening protocols for a number of diseases because of their skills and easy access.Objective:To evaluate the prevalence of skin cancer risk factors and the photoprotection habits with a questionnaire in community pharmacy users.Methods:A research group consisting of pharmacists and dermatologists conducted a descriptive cross-sectional study to assess photoprotection habits and skin cancer risk factors by using a validated questionnaire in 218 community pharmacies in Barcelona from May 23rd to June 13th 2016. All participants received health education on photoprotection and skin cancer prevention. Patients with ≥1 skin cancer risk factor were referred to their physician, as they needed further screening of skin cancer.Results:A total of 5,530 participants were evaluated. Of those, only 20.2% participants had received a total body skin examination for skin cancer screening in the past by a physician and 57.1% reported using a SPF 50+ sunscreen. 53.9% participants presented ≥1 skin cancer risk factor: 11.8% participants reported having skin cancer familial history and 6.2% reported skin cancer personal history; pharmacists found ≥10 melanocytic nevi in 43.8% participants and chronically sun-damaged skin in 21.4%. Lesions suspicious for melanoma were reported in 10.9% of the participants and urgent dermatological evaluation was recommended.Conclusions:Pharmacists can detect people with skin cancer risk factors amongst their users. This intervention can be considered in multidisciplinary strategies of skin cancer screening.

show abstract

Section: Discussionmentioning

confidence: 98%